Recherchemedicale.com
Tumeurs
Tumeurs par type histologique
Tumeurs épithéliales épidermoïdes et glandulaires
Tumeurs épidermoïdes
Carcinome verruqueux
Carcinome verruqueux : Questions médicales fréquentes
Diagnostic
5
Carcinome verruqueux
Biopsie
Examen clinique
Histopathologie
Carcinome verruqueux
Biopsie
Carcinome verruqueux
Lésions cutanées
Examen clinique
Carcinome verruqueux
Marqueurs tumoraux
Diagnostic
Imagerie médicale
Carcinome verruqueux
Métastases
Symptômes
5
Carcinome verruqueux
Symptômes
Lésions cutanées
Carcinome verruqueux
Démangeaisons
Lésions cutanées
Carcinome verruqueux
Saignements
Lésions cutanées
Carcinome verruqueux
Localisation
Symptômes
Carcinome verruqueux
Symptômes systémiques
Cancer
Prévention
5
Prévention
Carcinome verruqueux
Exposition au soleil
Vaccin VPH
Carcinome verruqueux
Prévention
Surveillance
Carcinome verruqueux
Lésions cutanées
Protection solaire
Carcinome verruqueux
Prévention
Tabagisme
Carcinome verruqueux
Prévention
Traitements
5
Carcinome verruqueux
Chirurgie
Radiothérapie
Chirurgie
Carcinome verruqueux
Traitement
Radiothérapie
Carcinome verruqueux
Traitement
Traitements topiques
Carcinome verruqueux
Lésions cutanées
Chimiothérapie
Carcinome verruqueux
Traitement
Complications
5
Complications
Carcinome verruqueux
Métastases
Récidive
Carcinome verruqueux
Traitement
Complications
Chirurgie
Carcinome verruqueux
Qualité de vie
Carcinome verruqueux
Impact psychologique
Complications
Carcinome verruqueux
Douleurs chroniques
Facteurs de risque
5
Facteurs de risque
Carcinome verruqueux
VPH
Tabagisme
Carcinome verruqueux
Facteurs de risque
Âge
Carcinome verruqueux
Facteurs de risque
Antécédents familiaux
Carcinome verruqueux
Facteurs de risque
Immunodépression
Carcinome verruqueux
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carcinome verruqueux : Questions médicales les plus fréquentes",
"headline": "Carcinome verruqueux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carcinome verruqueux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2024-12-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carcinome verruqueux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs épidermoïdes",
"url": "https://recherchemedicale.com/mesh/D018307",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs épidermoïdes",
"code": {
"@type": "MedicalCode",
"code": "D018307",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Carcinome verruqueux",
"alternateName": "Carcinoma, Verrucous",
"code": {
"@type": "MedicalCode",
"code": "D018289",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pablo Agustin Vargas",
"url": "https://recherchemedicale.com/author/Pablo%20Agustin%20Vargas",
"affiliation": {
"@type": "Organization",
"name": "Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil; Department of Oral Pathology, University of Pretoria, Pretoria, South Africa."
}
},
{
"@type": "Person",
"name": "Alan Roger Santos-Silva",
"url": "https://recherchemedicale.com/author/Alan%20Roger%20Santos-Silva",
"affiliation": {
"@type": "Organization",
"name": "Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil."
}
},
{
"@type": "Person",
"name": "Phetmany Sihavong",
"url": "https://recherchemedicale.com/author/Phetmany%20Sihavong",
"affiliation": {
"@type": "Organization",
"name": "Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand."
}
},
{
"@type": "Person",
"name": "Nakarin Kitkumthorn",
"url": "https://recherchemedicale.com/author/Nakarin%20Kitkumthorn",
"affiliation": {
"@type": "Organization",
"name": "Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand."
}
},
{
"@type": "Person",
"name": "Dusit Bumalee",
"url": "https://recherchemedicale.com/author/Dusit%20Bumalee",
"affiliation": {
"@type": "Organization",
"name": "Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Proliferative verrucous leukoplakia: a case report of multiple metachronous oral verrucous carcinoma.",
"datePublished": "2023-11-15",
"url": "https://recherchemedicale.com/article/37967933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2023-256383"
}
},
{
"@type": "ScholarlyArticle",
"name": "Surgical treatment of verrucous carcinoma: a review.",
"datePublished": "2022-06-13",
"url": "https://recherchemedicale.com/article/33849379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09546634.2021.1914312"
}
},
{
"@type": "ScholarlyArticle",
"name": "Verrucous carcinoma presenting as recalcitrant verruca plantaris.",
"datePublished": "2024-03-15",
"url": "https://recherchemedicale.com/article/38762863",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5070/D330163293"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oral verrucous carcinoma: a diagnostic and therapeutic challenge.",
"datePublished": "2023-03-22",
"url": "https://recherchemedicale.com/article/36942907",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2478/raon-2023-0015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Verrucous Carcinoma Arising in an Extended Giant Condyloma Acuminatum.",
"datePublished": "2023-03-29",
"url": "https://recherchemedicale.com/article/36987831",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://recherchemedicale.com/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://recherchemedicale.com/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs épidermoïdes",
"item": "https://recherchemedicale.com/mesh/D018307"
},
{
"@type": "ListItem",
"position": 6,
"name": "Carcinome verruqueux",
"item": "https://recherchemedicale.com/mesh/D018289"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carcinome verruqueux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carcinome verruqueux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-22",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carcinome verruqueux",
"description": "Comment diagnostique-t-on un carcinome verruqueux ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLe carcinome verruqueux est-il visible à l'œil nu ?\nY a-t-il des marqueurs tumoraux spécifiques ?\nLe diagnostic nécessite-t-il une imagerie ?",
"url": "https://recherchemedicale.com/mesh/D018289#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carcinome verruqueux",
"description": "Quels sont les symptômes du carcinome verruqueux ?\nLes lésions sont-elles douloureuses ?\nPeut-on observer des saignements ?\nLes symptômes varient-ils selon l'emplacement ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://recherchemedicale.com/mesh/D018289#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carcinome verruqueux",
"description": "Comment prévenir le carcinome verruqueux ?\nLe vaccin contre le VPH aide-t-il ?\nFaut-il surveiller les lésions cutanées ?\nLes protections solaires sont-elles efficaces ?\nY a-t-il des habitudes à éviter ?",
"url": "https://recherchemedicale.com/mesh/D018289#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carcinome verruqueux",
"description": "Quels traitements sont disponibles pour le carcinome verruqueux ?\nLa chirurgie est-elle toujours nécessaire ?\nLa radiothérapie est-elle efficace ?\nDes traitements topiques sont-ils possibles ?\nLa chimiothérapie est-elle couramment utilisée ?",
"url": "https://recherchemedicale.com/mesh/D018289#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carcinome verruqueux",
"description": "Quelles sont les complications possibles du carcinome verruqueux ?\nLe carcinome verruqueux peut-il récidiver ?\nY a-t-il des risques de complications après traitement ?\nLe carcinome verruqueux affecte-t-il la qualité de vie ?\nDes complications à long terme sont-elles possibles ?",
"url": "https://recherchemedicale.com/mesh/D018289#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carcinome verruqueux",
"description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes antécédents familiaux sont-ils importants ?\nLes personnes immunodéprimées sont-elles à risque ?",
"url": "https://recherchemedicale.com/mesh/D018289#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un carcinome verruqueux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et la biopsie des lésions suspectes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests histopathologiques sont effectués sur les échantillons de biopsie."
}
},
{
"@type": "Question",
"name": "Le carcinome verruqueux est-il visible à l'œil nu ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il se présente souvent sous forme de lésions verruqueuses visibles sur la peau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs tumoraux spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de marqueurs tumoraux spécifiques pour le carcinome verruqueux."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il une imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est généralement pas nécessaire, sauf en cas de suspicion de métastases."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du carcinome verruqueux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des lésions verruqueuses, souvent indolores, sur la peau."
}
},
{
"@type": "Question",
"name": "Les lésions sont-elles douloureuses ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, les lésions sont indolores, mais peuvent provoquer des démangeaisons."
}
},
{
"@type": "Question",
"name": "Peut-on observer des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements peuvent survenir si les lésions sont irritées ou traumatisées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'emplacement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la localisation des lésions sur le corps."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes systémiques sont rares, le carcinome verruqueux est localisé."
}
},
{
"@type": "Question",
"name": "Comment prévenir le carcinome verruqueux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'évitement des expositions prolongées au soleil et des VPH."
}
},
{
"@type": "Question",
"name": "Le vaccin contre le VPH aide-t-il ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre le VPH peut réduire le risque de carcinome verruqueux associé au virus."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les lésions cutanées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière des lésions cutanées est recommandée pour détecter des changements."
}
},
{
"@type": "Question",
"name": "Les protections solaires sont-elles efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de protections solaires peut aider à prévenir les lésions cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et les comportements à risque peut réduire le risque de carcinome."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le carcinome verruqueux ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et parfois la chimiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent le traitement de choix, surtout pour les lésions localisées."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée pour les cas avancés ou inopérables."
}
},
{
"@type": "Question",
"name": "Des traitements topiques sont-ils possibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements topiques peuvent être envisagés pour les lésions superficielles."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle couramment utilisée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie est rarement utilisée, sauf dans les cas avancés ou métastatiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du carcinome verruqueux ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation locale et, dans de rares cas, des métastases."
}
},
{
"@type": "Question",
"name": "Le carcinome verruqueux peut-il récidiver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive, surtout si les lésions ne sont pas complètement excisées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent survenir après la chirurgie, comme des infections ou des cicatrices."
}
},
{
"@type": "Question",
"name": "Le carcinome verruqueux affecte-t-il la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les lésions peuvent affecter l'estime de soi et la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Des complications à long terme sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme peuvent inclure des modifications cutanées et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'exposition au soleil, le tabagisme et l'infection par le VPH."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour plusieurs types de cancers cutanés."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout chez les personnes de plus de 50 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancers cutanés peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ont un risque accru de développer des cancers cutanés."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/12/2024
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil; Department of Oral Pathology, University of Pretoria, Pretoria, South Africa.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Oral Biology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Mahidol University, Bangkok, 10400, Thailand. puangwan.lap@mahidol.ac.th.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Dental Surgery, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Faculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Dental Surgery, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Faculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Publications dans "Carcinome verruqueux" :
2 publications dans cette catégorie
Affiliations :
Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, USA.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil. Electronic address: carla.rodrigues212@gmail.com.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Oral Diagnosis, Semiology and Pathology Areas, Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Dermatology, Emergency County Hospital, Craiova, University of Medicine and Pharmacy of Craiova, Romania.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Dermatology, Emergency County Hospital, Craiova, University of Medicine and Pharmacy of Craiova, Romania.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology, Emergency County Hospital, Craiova, University of Medicine and Pharmacy of Craiova, Romania.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Oral Medicine and Radiology, Sri Rajiv Gandhi College of Dental Sciences, Bengaluru, Karnataka, India.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Oral Medicine and Radiology, Sri Rajiv Gandhi College of Dental Sciences, Bengaluru, Karnataka, India.
Publications dans "Carcinome verruqueux" :
1 publication dans cette catégorie
Affiliations :
Department of Oral Medicine and Radiology, Sri Rajiv Gandhi College of Dental Sciences, Bengaluru, Karnataka, India.
Publications dans "Carcinome verruqueux" :
Proliferative verrucous leukoplakia (PVL) is a distinct progressive and multi-focal form of oral leukoplakia, not associated with the traditional risk factors (ie, tobacco and alcohol consumption). Th...
Verrucous carcinoma is a rare mucocutaneous malignancy characterized by slow, relentless growth and a low metastasis rate....
Herein we summarize surgical success rates and review newer approaches to the treatment of verrucous carcinomas....
PubMed electronic searches were performed by B.F. and C.V. using combinations of the following terms: "verrucous carcinoma," "Ackerman tumor," "Buschke Lowenstein," "epithelioma cuniculatum," "carcino...
Surgical management remains first-line therapy. Wide local excision is most commonly utilized, with highly variable margins (0.5-3.0 cm) and recurrence rates (4.6-75.0%). Mohs Micrographic Surgery has...
Surgery is the treatment of choice, either by Mohs Micrographic Surgery or wide local excision. However, surgical recurrence rates are high, and tissue-sparing therapies are desirable given the sensit...
Verrucous carcinoma (VC) is a rare, low-grade variant of well-differentiated squamous cell carcinoma. Plantar verrucous carcinoma presents as a slow-growing, exophytic, verrucous plaque on weight bear...
Verrucous carcinoma is a low-grade variant of squamous cell carcinoma with specific morphologic, cytokinetic and clinical features. Despite low mitotic activity and slow growth, it can infiltrate adja...
Oral verrucous carcinoma must be differentiated from conventional squamous cell carcinoma due to its less aggressive behaviour with a more favourable prognosis. Close communication between clinician a...
A 43-year-old heterosexual Tunisian man presented to the dermatology department with complaints of a genital friable mass. He had a past medical history of chronic hepatitis B. He was married and had ...
Verrucous carcinoma, a low-grade variant of squamous cell carcinoma, defined as a diagnostically squamous cell neoplasia involving lip, oropharyngeal, and laryngeal mucosa and named as 'Ackerman's tum...
Verrucous carcinoma is a rare, low grade variant of squamous cell carcinoma that rarely metastasizes but tends to display aggressive local behavior. Wide local excision is the most common treatment, b...
Marjolin's ulcer is the malignant degeneration of any chronic wound, with a latency period from tissue injury to variable malignant transformation that may occur up to 30 years later. Among the associ...
65-year-old female patient with a history of being a carrier of human immunodeficiency virus (HIV) infection, who presented a verrucous carcinoma associated to a Marjolin ulcer secondary to herpes zos...
The finding of a verrucous carcinoma on a Marjolin ulcer has been little described in literature, with a lower incidence in the context of a patient with a history of being a carrier of HIV infection,...
Verrucous vulvar carcinoma (VC) is an uncommon and distinct histologic subtype of squamous cell carcinoma (SCC). The available literature on VC is currently limited to case reports and small single in...
The goals of this study were to analyze data from the National Cancer Database (NCDB) to quantitate the incidence of VC and to investigate the effects of patient demographics, tumor characteristics, a...
Patients diagnosed with vulvar SCC or VC between the years of 2004 and 2016 were identified in the NCDB. OS was assessed with Kaplan-Meier curves and the log-rank test. Construction of a Cox model com...
Verrucous carcinoma is more likely to present in older women. Regional lymph node surgery in addition to primary site surgery significantly improves OS in VC patients....
To investigate the survival benefit of elective neck dissection (END) over neck observation in cT1-4 N0M0 head and neck verrucous carcinoma (HNVC)....
Retrospective cohort study....
The 2006 to 2017 National Cancer Database....
Patients with surgically resected cT1-4 N0M0 HNVC were selected. Linear, binary logistic, Kaplan-Meier, and Cox proportional hazards regression models were utilized....
Of 1015 patients satisfying inclusion criteria, 223 (22.0%) underwent END. The majority of patients were male (55.4%) and white (91.0%) with disease of the oral cavity (67.6%) classified as low grade ...
END does not confer an appreciable survival benefit in HNVC, even after stratifying univariate and multivariate analyses by several patient, facility, tumor, and treatment characteristics....
Level 4....